Berenberg Bank reissued their sell rating on shares of Mallinckrodt (NYSE:MNK) in a research report sent to investors on Tuesday morning, The Fly reports. They currently have a $5.00 target price on the stock, down from their prior target price of $10.00.

Other research analysts have also recently issued reports about the company. Canaccord Genuity set a $40.00 price objective on Mallinckrodt and gave the stock a buy rating in a research report on Monday, March 18th. Morgan Stanley set a $32.00 price objective on Mallinckrodt and gave the stock a hold rating in a research report on Thursday, February 28th. ValuEngine raised Mallinckrodt from a sell rating to a hold rating in a research report on Monday, February 4th. SunTrust Banks set a $20.00 price objective on Mallinckrodt and gave the stock a hold rating in a research report on Tuesday, May 14th. Finally, Mizuho reduced their price objective on Mallinckrodt from $25.00 to $22.00 and set a neutral rating for the company in a research report on Thursday, May 16th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $27.65.

NYSE:MNK opened at $9.10 on Tuesday. Mallinckrodt has a 1 year low of $8.45 and a 1 year high of $36.65. The company has a quick ratio of 1.08, a current ratio of 1.45 and a debt-to-equity ratio of 1.90. The stock has a market capitalization of $827.24 million, a price-to-earnings ratio of 1.14, a price-to-earnings-growth ratio of 0.10 and a beta of 2.12.

Mallinckrodt (NYSE:MNK) last posted its earnings results on Tuesday, May 7th. The company reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.21. The firm had revenue of $791.00 million during the quarter, compared to analysts’ expectations of $766.27 million. Mallinckrodt had a positive return on equity of 14.22% and a negative net margin of 118.53%. The company’s revenue was up 4.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 earnings per share. As a group, equities research analysts anticipate that Mallinckrodt will post 8.38 earnings per share for the current year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MNK. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in Mallinckrodt during the first quarter worth about $47,464,000. Norges Bank bought a new stake in Mallinckrodt during the fourth quarter worth about $26,615,000. Dimensional Fund Advisors LP raised its holdings in Mallinckrodt by 15.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,357,117 shares of the company’s stock worth $100,443,000 after acquiring an additional 840,414 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Mallinckrodt by 90.6% during the fourth quarter. Acadian Asset Management LLC now owns 1,694,860 shares of the company’s stock worth $26,781,000 after acquiring an additional 805,751 shares in the last quarter. Finally, LSV Asset Management raised its holdings in Mallinckrodt by 21.1% during the fourth quarter. LSV Asset Management now owns 4,090,968 shares of the company’s stock worth $64,637,000 after acquiring an additional 713,709 shares in the last quarter.

About Mallinckrodt

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Read More: Understanding Price to Earnings Ratio (PE)

The Fly

Analyst Recommendations for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.